Published in Br J Cancer on March 20, 2007
Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci (2009) 2.85
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One (2010) 2.21
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One (2011) 1.57
Immunotherapeutic approaches for glioma. Crit Rev Immunol (2009) 1.55
Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol (2009) 1.45
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res (2010) 1.37
Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells (2010) 1.29
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun (2007) 1.20
Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Neoplasia (2014) 1.10
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget (2011) 1.09
Targeting Aggressive Cancer Stem Cells in Glioblastoma. Front Oncol (2015) 1.05
Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae (2011) 1.05
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. Mol Cancer (2011) 0.98
Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma. Neuroscience (2010) 0.96
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med (2013) 0.95
Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy. Blood (2015) 0.93
Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? Neuropharmacology (2010) 0.93
Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway. Oncogenesis (2014) 0.91
Immunity to stemness genes in human cancer. Curr Opin Immunol (2010) 0.89
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer. Oncogene (2015) 0.89
T cell-tumor interaction directs the development of immunotherapies in head and neck cancer. Clin Dev Immunol (2010) 0.89
Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures. Int J Clin Exp Pathol (2013) 0.88
Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres. J Oncol (2011) 0.88
Studying a complex tumor: potential and pitfalls. Cancer J (2012) 0.87
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme. Front Surg (2016) 0.87
Anti-cancer Therapies in High Grade Gliomas. Curr Proteomics (2013) 0.86
PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells. Br J Cancer (2012) 0.86
Visualization of implanted GL261 glioma cells in living mouse brain slices using fluorescent 4-(4-(dimethylamino)-styryl)-N-methylpyridinium iodide (ASP+). Biotechniques (2012) 0.85
Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells (2011) 0.85
Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells. J Histochem Cytochem (2015) 0.85
Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12. Am J Pathol (2011) 0.84
Glioma stem cells and immunotherapy for the treatment of malignant gliomas. ISRN Oncol (2013) 0.84
Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. J Cancer Res Clin Oncol (2012) 0.84
Malignant clinical features of anaplastic gliomas without IDH mutation. Neuro Oncol (2014) 0.83
Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer (2014) 0.83
SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours. Hum Mutat (2011) 0.82
Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression. Carcinogenesis (2012) 0.82
Cancer Stem Cells in Glioblastoma Multiforme. Front Surg (2016) 0.82
Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges. Cancer Immunol Immunother (2010) 0.81
Vaccines targeting cancer stem cells: are they within reach? Cancer J (2011) 0.81
Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin System. Front Surg (2016) 0.81
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma. Front Oncol (2014) 0.80
Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma. Exp Ther Med (2015) 0.79
Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma. J Immunol Res (2014) 0.79
Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis. Obstet Gynecol Int (2010) 0.79
Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP(+) substrate to the nuclei. J Neurosci Neuroeng (2014) 0.78
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation. Clin Dev Immunol (2011) 0.78
A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles. Transl Oncol (2012) 0.77
Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther (2016) 0.77
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma. Front Oncol (2016) 0.76
Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma. Neuroscience (2017) 0.76
Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion. PLoS One (2017) 0.75
Metformin treatment reduces temozolomide resistance of glioblastoma cells. Oncotarget (2016) 0.75
Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacol Sin (2017) 0.75
Neural stem/progenitor cells react to non-glial cns neoplasms. Springerplus (2015) 0.75
SOX2 immunity and tissue resident memory in children and young adults with glioma. J Neurooncol (2017) 0.75
Utility of SOX2 and Livin Co-Expression in the Prognosis of Bladder Cancer With Bilharzial and Non-Bilharzial Bladder Status. World J Oncol (2015) 0.75
Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA. Clin Exp Metastasis (2016) 0.75
SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics (1999) 14.15
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54
Mutations in SOX2 cause anophthalmia. Nat Genet (2003) 5.03
From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res (1999) 4.64
Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet (2000) 3.82
Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell (2002) 3.39
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res (2005) 3.35
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res (2004) 2.89
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res (2001) 2.11
Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neuronal development. Mech Dev (1995) 2.09
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02
Brain tumor survival: results from the National Cancer Data Base. J Neurooncol (1998) 1.98
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol (2006) 1.86
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res (2005) 1.76
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer (2003) 1.63
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol (2004) 1.59
EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia (2005) 1.49
Sox genes and cancer. Cytogenet Genome Res (2004) 1.42
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain. Clin Cancer Res (2002) 1.42
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. Br J Cancer (2004) 1.39
Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep (2005) 1.37
Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol (2006) 1.32
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res (2004) 1.26
Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc Natl Acad Sci U S A (1996) 1.22
An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum Immunol (1995) 1.11
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol (1997) 1.11
Advances in the molecular genetics of gliomas. Curr Opin Oncol (1997) 1.10
T cell adoptive immunotherapy of newly diagnosed gliomas. Clin Cancer Res (2000) 1.08
Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene (2004) 1.05
AIM-2: a novel tumor antigen is expressed and presented by human glioma cells. J Immunother (2004) 1.00
Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients. Int J Cancer (2002) 0.98
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma. J Immunother (2003) 0.97
Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J Immunol (2004) 0.96
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms. Int J Cancer (1998) 0.96
Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. J Neurooncol (2006) 0.96
Expression of the tumor-rejection antigen SART1 in brain tumors. Int J Cancer (1999) 0.93
Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials. Cancer Control (2004) 0.92
Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides. J Immunother (2001) 0.90
Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas. Clin Cancer Res (2003) 0.89
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11. Cancer Lett (2006) 0.84
UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour. Br J Cancer (2002) 0.84
Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors. Tissue Antigens (2002) 0.83
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Biochem Biophys Res Commun (2004) 0.82
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 21.24
Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 6.54
The receptor for the cytotoxic ligand TRAIL. Science (1997) 6.39
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol (1994) 6.00
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Path integration in desert ants, Cataglyphis fortis. Proc Natl Acad Sci U S A (1988) 2.45
The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess (2005) 2.38
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science (1993) 2.35
Transmission of glioblastoma multiforme through liver transplantation. Lancet (1998) 2.33
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (1992) 2.27
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol (1999) 2.16
Oceili: a celestial compass in the desert ant cataglyphis. Science (1985) 2.10
The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity (1998) 2.06
Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (1993) 2.02
A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem (1999) 1.98
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
Ant odometry in the third dimension. Nature (2001) 1.71
Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur J Immunol (1996) 1.68
Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A (1996) 1.68
Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol (2000) 1.68
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J (2000) 1.67
Sugar permeases of the bacterial phosphoenolpyruvate-dependent phosphotransferase system: sequence comparisons. FASEB J (1988) 1.64
How the clear-sky angle of polarization pattern continues underneath clouds: full-sky measurements and implications for animal orientation. J Exp Biol (2001) 1.63
Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis (2000) 1.61
The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol (1998) 1.58
The Practical Approach to Lung Health in South Africa (PALSA) intervention: respiratory guideline implementation for nurse trainers. Int Nurs Rev (2006) 1.58
A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem (2000) 1.54
Evaluation of efficacy and plasma concentrations of ropivacaine in continuous axillary brachial plexus block: high dose for surgical anesthesia and low dose for postoperative analgesia. Reg Anesth Pain Med (2000) 1.53
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood (1999) 1.52
Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol (1998) 1.49
Plasmid-mediated sucrose metabolism in Escherichia coli K12: mapping of the scr genes of pUR400. Mol Microbiol (1988) 1.44
Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis. Gut (2009) 1.43
Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res (1997) 1.43
Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol (1993) 1.42
In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem (1994) 1.40
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Clinical research: is the filling missing from the medical research sandwich? J R Coll Physicians Lond (2000) 1.39
Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res (1995) 1.37
Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien) (2001) 1.37
Molecular analysis of two fructokinases involved in sucrose metabolism of enteric bacteria. Mol Microbiol (1991) 1.35
Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology (2001) 1.34
The guidance of desert ants by extended landmarks. J Exp Biol (2001) 1.30
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods (2001) 1.30
Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J Cell Biol (1992) 1.30
Restrictions on rotational and translational diffusion of pigment in the membranes of a rhabdomeric photoreceptor. J Gen Physiol (1977) 1.30
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin Cancer Res (1997) 1.29
Heat shock protein synthesis and thermotolerance in Cataglyphis, an ant from the Sahara desert. Proc Natl Acad Sci U S A (1995) 1.29
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay. Int J Cancer (1997) 1.28
Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum (1991) 1.28
A sugar-specific porin, ScrY, is involved in sucrose uptake in enteric bacteria. Mol Microbiol (1991) 1.27
Calibration of vector navigation in desert ants. Curr Biol (1999) 1.27
Design and analysis of studies evaluating smoking cessation interventions where effects vary between practices or practitioners. Fam Pract (1996) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.26
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med (1987) 1.23
[Visual fields of the central ommatidia in the compound eye of Apis mellifica and Cataglyphis bicolor (Apidae, Formicidae; Hymenoptera)]. Kybernetik (1972) 1.23
Pinpointing food sources: olfactory and anemotactic orientation in desert ants, Cataglyphis fortis. J Exp Biol (2000) 1.23
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol (1997) 1.22
Efficient immune responses in mice lacking N-region diversity. Eur J Immunol (1995) 1.22
The biology of melanoma brain metastasis. Cancer Metastasis Rev (1999) 1.21
Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res (2000) 1.20
Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis (1999) 1.19
Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res (2000) 1.19
Transport of mRNA from nucleus to cytoplasm. Prog Nucleic Acid Res Mol Biol (1987) 1.17
A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol (1998) 1.17
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J Exp Med (1989) 1.16
Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J Exp Med (1997) 1.15
The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate. J Biol Chem (2000) 1.15
The bee's map of the e-vector pattern in the sky. Proc Natl Acad Sci U S A (1982) 1.13
Optic neuropathy associated with laser in situ keratomileusis. J Cataract Refract Surg (2000) 1.13
Expression of M-cadherin protein in myogenic cells during prenatal mouse development and differentiation of embryonic stem cells in culture. Dev Dyn (1994) 1.12
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol (1997) 1.11
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia (2012) 1.11
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer (2004) 1.11
Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1992) 1.11
Purification and Partial Characterization of an Aminopeptidase from Lactobacillus lactis. Appl Environ Microbiol (1980) 1.11
Polarized-light navigation by insects. Sci Am (1976) 1.11
Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development (1994) 1.10
Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer (2001) 1.10
Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol (1993) 1.10
Functional similarities between polarization vision and color vision. Vision Res (1977) 1.10
Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09
Molecular analysis of the scrA and scrB genes from Klebsiella pneumoniae and plasmid pUR400, which encode the sucrose transport protein Enzyme II Scr of the phosphotransferase system and a sucrose-6-phosphate invertase. Mol Gen Genet (1996) 1.09
Suppression of graft versus host reaction by univalent anti-immunoglobulin antibody. Nat New Biol (1971) 1.09
IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur J Immunol (1990) 1.08
Hydatid cysts of the orbit. A review of 35 cases. Ophthalmology (1988) 1.08
Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J Biol Chem (1987) 1.08
Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study. Anesth Analg (1983) 1.08
Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med (1992) 1.08
Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol (1999) 1.07
Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol (2001) 1.07